Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.

adenovirus brincidofovir renal transplantation

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 04 02 2021
accepted: 23 02 2021
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 14 8 2021
Statut: epublish

Résumé

Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection. Two renal transplant recipients with HAdV-11 infection who received kidneys from the same donor are described. Whole-genome sequencing (WGS) was performed. WGS showed 100% nucleotide sequence identity for the 2 HAdV-11 isolates. The patients presented with distinct clinical syndromes, and both were treated with brincidofovir. Donor-derived HAdV infection is presumed to be low; however, disseminated HAdV in SOT recipients can be severe, and clinicians should be aware of the clinical course and treatment options.

Sections du résumé

BACKGROUND BACKGROUND
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
METHODS METHODS
Two renal transplant recipients with HAdV-11 infection who received kidneys from the same donor are described. Whole-genome sequencing (WGS) was performed.
RESULTS RESULTS
WGS showed 100% nucleotide sequence identity for the 2 HAdV-11 isolates. The patients presented with distinct clinical syndromes, and both were treated with brincidofovir.
CONCLUSIONS CONCLUSIONS
Donor-derived HAdV infection is presumed to be low; however, disseminated HAdV in SOT recipients can be severe, and clinicians should be aware of the clinical course and treatment options.

Identifiants

pubmed: 34386544
doi: 10.1093/ofid/ofab092
pii: ofab092
pmc: PMC8355461
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ofab092

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Blood. 2017 Apr 6;129(14):2033-2037
pubmed: 28153824
Clin Microbiol Infect. 2016 Apr;22(4):381.e1-381.e8
pubmed: 26711435
Open Forum Infect Dis. 2018 Dec 26;6(3):ofy354
pubmed: 30882008
Clin Infect Dis. 2006 Aug 1;43(3):331-9
pubmed: 16804849
J Virol. 2002 Nov;76(21):10608-16
pubmed: 12368303
Nephrol Dial Transplant. 2013 Aug;28(8):2003-10
pubmed: 23493328
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7
pubmed: 18490659
NDT Plus. 2009 Jun;2(3):250-3
pubmed: 25984003
J Infect Dis. 1994 Apr;169(4):775-81
pubmed: 8133091
Am J Transplant. 2005 Oct;5(10):2555-9
pubmed: 16162207
Arch Virol. 2006 Aug;151(8):1587-602
pubmed: 16502282
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Hum Pathol. 2007 Sep;38(9):1412-9
pubmed: 17602724
Transpl Infect Dis. 2016 Apr;18(2):234-9
pubmed: 26919131
J Virol. 2009 Mar;83(6):2417-28
pubmed: 19109384
MMWR Morb Mortal Wkly Rep. 2017 Oct 06;66(39):1039-1042
pubmed: 28981484
Curr Opin Infect Dis. 2002 Aug;15(4):355-67
pubmed: 12130931

Auteurs

Amy C Sherman (AC)

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Xiaoyan Lu (X)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Eileen Schneider (E)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Amelia Langston (A)

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.

Carla L Ellis (CL)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Stephen Pastan (S)

Division of Renal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Julu Bhatnagar (J)

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sarah Reagan-Steiner (S)

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Pallavi Annambhotla (P)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Stephen Lindstrom (S)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aneesh Mehta (A)

Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.

Stephanie M Pouch (SM)

Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.

Marybeth E Sexton (ME)

Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.

Classifications MeSH